J. Wolk Joseph's most recent trade in Johnson & Johnson was a trade of 91,277 Employee Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Feb. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 91,277 | 91,277 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 5,632 | 5,632 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 15,316 | 20,661 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 15,316 | 0 | - | - | Performance Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.71 per share. | 13 Feb 2025 | 6,661 | 14,000 (0%) | 0% | 156.7 | 1,043,845 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,014 | 5,286 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,014 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,971 | 6,113 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,971 | 3,942 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,779 | 1,779 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,779 | 1,779 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.71 per share. | 13 Feb 2025 | 1,144 | 4,142 (0%) | 0% | 156.7 | 179,276 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.15 per share. | 13 Feb 2025 | 768 | 5,345 (0%) | 0% | 156.1 | 119,923 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 155.26 per share. | 13 Feb 2025 | 507 | 1,272 (0%) | 0% | 155.3 | 78,717 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 15,316 | 15,316 | - | - | Performance Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Sale of securities on an exchange or to another person at price $ 153.89 per share. | 07 Feb 2025 | 13,015 | 0 (0%) | 0% | 153.9 | 2,002,878 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 13,015 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.06 per share. | 07 Feb 2025 | 13,015 | 13,015 (0%) | 0% | 100.1 | 1,302,281 | Common Stock |
| Kenvue Inc | Joseph J. Wolk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 9,259 | 17,188 | - | - | Deferred Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 May 2024 | 68,835 | 0 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 May 2024 | 68,835 | 68,835 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 May 2024 | 55 | 68,835 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | J. Joseph Wolk | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 95,197 | 95,197 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | J. Wolk Joseph | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 5,913 | 5,913 | - | - | Restricted Share Units | |
| Johnson & Johnson | J. Joseph Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 1,780 | 69,663 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph Wolk J. | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 1,780 | 3,558 | - | - | Restricted Share Units | |
| Johnson & Johnson | Wolk J. Joseph | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.85 per share. | 13 Feb 2024 | 773 | 68,890 (0%) | 0% | 157.8 | 122,018 | Common Stock |
| Johnson & Johnson | Wolk J. Joseph | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 22,119 | 0 | - | - | Performance Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 22,119 | 74,983 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | J. Joseph Wolk | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.40 per share. | 12 Feb 2024 | 10,816 | 67,883 (0%) | 0% | 157.4 | 1,702,438 | Common Stock |
| Johnson & Johnson | J. Wolk Joseph | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 3,716 | 78,699 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | J. Wolk Joseph | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 3,686 | 53,911 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph Wolk J. | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 3,686 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Wolk J. Joseph | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.33 per share. | 08 Feb 2024 | 1,047 | 52,864 (0%) | 0% | 156.3 | 163,678 | Common Stock |
| Kenvue Inc | Joseph J. Wolk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 7,620 | 7,620 | - | - | Deferred Share Units | |
| Kenvue Inc | Joseph J. Wolk | Director | Other type of transaction at price $ 0.00 per share. | 23 Aug 2023 | 538 | 538 | - | - | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Aug 2023 | 67 | 50,275 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 May 2023 | 55 | 50,342 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 88,334 | 88,334 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 20,693 | 58,975 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.01 per share. | 13 Feb 2023 | 8,578 | 50,397 (0%) | 0% | 162.0 | 1,389,722 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 5,338 | 5,338 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 3,449 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 3,449 | 39,261 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.08 per share. | 10 Feb 2023 | 979 | 38,282 (0%) | 0% | 162.1 | 158,676 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2022 | 12,926 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Sale of securities on an exchange or to another person at price $ 179.62 per share. | 13 Dec 2022 | 12,926 | 35,812 (0%) | 0% | 179.6 | 2,321,755 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.44 per share. | 13 Dec 2022 | 12,926 | 48,738 (0%) | 0% | 90.4 | 1,169,027 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2022 | 1,855 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Sale of securities on an exchange or to another person at price $ 179.46 per share. | 13 Dec 2022 | 1,855 | 48,738 (0%) | 0% | 179.5 | 332,906 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.54 per share. | 13 Dec 2022 | 1,855 | 50,593 (0%) | 0% | 72.5 | 134,562 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2022 | 28 | 35,812 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2022 | 18 | 35,840 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 79,280 | 79,280 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 17,793 | 1,695 | - | - | Performance Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 17,793 | 43,177 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.89 per share. | 14 Feb 2022 | 7,319 | 35,858 (0%) | 0% | 165.9 | 1,214,149 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 4,014 | 4,014 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 3,248 | 26,305 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 3,248 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 168.85 per share. | 14 Feb 2022 | 921 | 25,384 (0%) | 0% | 168.9 | 155,511 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 2,543 | 24,513 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 2,543 | 21,970 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 2,543 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 2,543 | 0 | - | - | Performance Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.55 per share. | 12 Feb 2021 | 733 | 23,057 (0%) | 0% | 165.5 | 121,348 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.55 per share. | 12 Feb 2021 | 723 | 23,790 (0%) | 0% | 165.6 | 119,693 | Common Stock |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 80,976 | 80,976 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 3,686 | 3,686 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joseph J. Wolk | Exec VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 2,543 | 2,543 | - | - | Performance Share Units |